Riskpilot← Back to searchSign inGet full accessAPOTEK OLSVIK AS
ASActiveOrg 923617825Olsvikåsen 8A, 5183 OlsvikRetail sale of pharmaceutical products · NACE 4773Est. 201914 employees
Revenue 2024
NOK 23,3M
+19% vs 2023
EBITDA margin
6.5%
+36% vs 2023
Equity ratio
1.9%
Financial strength
Net profit 2024
NOK 1,2M
+35% vs 2023
| Revenue | NOK 23,3M | +19% |
| EBITDA | NOK 1,5M | +36% |
| Net profit | NOK 1,2M | +35% |
| Total assets | NOK 4,6M | +1% |
| Equity | NOK 86K | -36% |
| Employees | 14 | — |
Legal name
APOTEK OLSVIK AS
Org number
923617825
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
16. oktober 2019
Share capital
NOK 30 000
Employees
14 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Company purpose
Eie og drive apotek, herunder konsulenttjenester innenfor apotekerbransjen og lege- og helserelaterte produkter, samt øvrig virksomhet i tilknytning til dette.
Address
Olsvikåsen 8A, 5183 Olsvik
Phone
+4755930331
Email
apotek1.olsvik@apotek1.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 16 991 | 17 747 | 18 002 | 19 559 | 23 291 |
| Staff expenses | −2 813 | −2 924 | −3 190 | −2 975 | −3 318 |
| EBITDA | 1 591 | 1 063 | 946 | 1 119 | 1 523 |
| Depreciation & amort. | −44 | −40 | −32 | −26 | −43 |
| EBIT | 1 547 | 1 023 | 914 | 1 093 | 1 480 |
| Net financials | 0 | 0 | 0 | −1 | −1 |
| Profit before tax | 1 547 | 1 023 | 914 | 1 092 | 1 479 |
| Tax | 338 | 226 | 201 | 240 | 328 |
| Net profit | 1 209 | 796 | 713 | 852 | 1 151 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 552 | 4 346 | 4 297 | 4 579 | 4 622 |
| Equity | 623 | 1 420 | 883 | 135 | 86 |
| Long-term debt | 1 | 6 | 5 | 4 | 3 |
| Short-term debt | 4 928 | 2 920 | 3 409 | 4 440 | 4 532 |
| Total debt | 4 929 | 2 926 | 3 414 | 4 444 | 4 536 |
EBITDA margin
6.5%
This company
15.8%
Market median
-59% vs market
20202024
Equity ratio
1.9%
This company
38.2%
Market median
-95% vs market
20202024
Return on equity
1339.2%
This company
18.4%
Market median
+7178% vs market
20202024
Net profit margin
4.9%
This company
8.1%
Market median
-40% vs market
20202024
Asset turnover
5.04×
This company
1.12×
Market median
+350% vs market
20202024
Debt / equity
52.77×
This company
0.62×
Market median
-8411% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Eversley Holding As
APOTEK OLSVIK AS Board members of APOTEK OLSVIK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Warren Sylvester Eversley | Board of Directors | 0 companies |
| Maya Henrika Eversley | Chairman | 0 companies |